Related Experiment Video
Updated: Feb 20, 2026
18:48
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
15.0K
Tolerance in clinical liver transplantation
1Division of Gastroenterology & Hepatology, Northwestern University, Chicago, IL, United States.
Human Immunology
|October 22, 2017
Summary
Liver transplant recipients face lifelong immunosuppression complications. New strategies and biomarkers are needed to safely withdraw these drugs and improve patient outcomes.
Area of Science:
- Immunology
- Transplantation Medicine
- Pharmacology
Background:
- Advances in immunosuppressive therapy reduce acute rejection after liver transplantation.
- Lifelong immunosuppression increases risks of malignancy, infection, metabolic disorders, and chronic kidney disease.
- High healthcare costs and drug monitoring are associated with maintenance immunosuppression.
Purpose of the Study:
- To review the mechanisms of liver transplant tolerance.
- To explore potential strategies for achieving immunosuppression withdrawal.
- To identify the need for immunomodulatory therapies and biomarkers for personalized drug tapering.
Main Methods:
- Literature review of mechanisms of liver transplant tolerance.
- Analysis of current strategies for immunosuppression minimization and withdrawal.
- Discussion of potential novel immunomodulatory therapies and biomarkers.
Main Results:
- Current immunosuppression withdrawal strategies have variable success rates.
- Development of early immunomodulatory therapies could enhance success.
- Biomarkers for immune activation are crucial for guiding personalized drug tapering.
Conclusions:
- Reducing long-term immunosuppression in liver transplant recipients is a critical goal.
- Further research into tolerance mechanisms and targeted therapies is essential.
- Personalized approaches using biomarkers are key to successful immunosuppression withdrawal.
More Related Videos
Related Concept Videos
01:24Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
01:28Kidney Transplant I: Introduction
537
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
537
01:26Kidney Transplant II: Surgical Procedure
492
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
492